The University of Michigan was awarded a $2,473,957 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will support research from June 2021 through June 2025 on the Physiologic Signaling and Exoskeleton Control of the Muscle Cuff Regenerative Peripheral Nerve Interface during Volitional Behavior. Through this funding, the University of Michigan will investigate medical solutions for the battlefield by...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
The University of Michigan will receive $725,000 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research to develop an angiogenic therapy to enhance and accelerate repair of traumatic bone defects. The University's Office of Research and Sponsored Projects will oversee delivery of the research services from September 1, 2022 through August 31, 2025 at their Ann Arbor, Michigan...
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
This $1,100,747 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research initiatives at the University of Michigan. The grant will fund the development of innovative antibody-drug conjugates that coordinate the innate and adaptive immune systems to generate curative responses. Over a three-year period from April 1, 2025 to March 31, 2028, the research aims to transform healthcare...
This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
The University of Michigan will receive $780,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to conduct a mixed-methods study from September 2021 through August 2024. The study will examine the risk of Alzheimer's disease and related dementias among people with spinal cord injuries, comparing veterans and civilians. Through supporting innovative medical research, the Military Medical Research and Development program...
The U.S. Department of Defense awarded a $143,709 Project Grant to the Regents of the University of Michigan under the Basic Scientific Research program (CFDA 12.431) to support foundational and applied research across diverse scientific and technical domains critical to national security. This grant, effective from January 15, 2025 to January 14, 2028, will fund the University of Michigan's research efforts aimed at advancing fundamental knowledge in areas such as quantum computing,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...